- Home
- ARTV vs AVTE Comparison
ARTV vs AVTE Comparison
Compare ARTV & AVTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTV
- AVTE
- Stock Information
- Founded
- ARTV 2019
- AVTE 2018
- Country
- ARTV United States
- AVTE United States
- Employees
- ARTV N/A
- AVTE N/A
- Industry
- ARTV
- AVTE Biotechnology: Pharmaceutical Preparations
- Sector
- ARTV
- AVTE Health Care
- Exchange
- ARTV NYSE
- AVTE Nasdaq
- Market Cap
- ARTV 61.9M
- AVTE 72.5M
- IPO Year
- ARTV 2024
- AVTE 2021
- Fundamental
- Price
- ARTV $2.24
- AVTE $2.75
- Analyst Decision
- ARTV Strong Buy
- AVTE Hold
- Analyst Count
- ARTV 7
- AVTE 7
- Target Price
- ARTV $20.00
- AVTE $11.75
- AVG Volume (30 Days)
- ARTV 679.3K
- AVTE 192.3K
- Earning Date
- ARTV 05-22-2025
- AVTE 05-12-2025
- Dividend Yield
- ARTV N/A
- AVTE N/A
- EPS Growth
- ARTV N/A
- AVTE N/A
- EPS
- ARTV N/A
- AVTE N/A
- Revenue
- ARTV $251,000.00
- AVTE N/A
- Revenue This Year
- ARTV N/A
- AVTE N/A
- Revenue Next Year
- ARTV N/A
- AVTE N/A
- P/E Ratio
- ARTV N/A
- AVTE N/A
- Revenue Growth
- ARTV N/A
- AVTE N/A
- 52 Week Low
- ARTV $1.78
- AVTE $1.25
- 52 Week High
- ARTV $17.31
- AVTE $25.29
- Technical
- Relative Strength Index (RSI)
- ARTV N/A
- AVTE 72.33
- Support Level
- ARTV N/A
- AVTE $2.61
- Resistance Level
- ARTV N/A
- AVTE $2.82
- Average True Range (ATR)
- ARTV 0.00
- AVTE 0.11
- MACD
- ARTV 0.00
- AVTE 0.02
- Stochastic Oscillator
- ARTV 0.00
- AVTE 81.08
About ARTV ARTIVA BIOTHERAPEUTICS INC
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).
About AVTE Aerovate Therapeutics Inc.
Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. The initial focus of the company is on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension.